MME and ovarian carcinoma: Research in the ovarian cancer TME has identified at least four different CAF subpopulations that express distinct molecular signatures characterized by variable expression of CD29, CD10, FAP, α-SMA, FSP1, PDGFR-β, podoplanin, and caveolin-1.